March 8, 2024 Rare Neurodegenerative Disease Efforts Under the ACT for ALS In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss...
January 30, 2024 Webinar Recording: TRxA 2024 Funding Opportunities TRxA’s focus is translating early-stage novel therapeutics into Investigational New Drug (IND) supporting data packages that...
January 16, 2024 C-Path weighs in on key topics to advance Real-World Data and Artificial Intelligence in Rare Diseases Vice President, Cécile Ollivier, serves on a panel of distinguished experts in the EJP RD-EFPIA Joint Advanced Webinar on...
December 8, 2023 Understanding the Role of Patient Data in Drug Development Panel within a session titled “Understanding the role of patient data in drug development” at the 2023 International...
November 16, 2023 C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
August 9, 2023 C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy C-Path's Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce...
July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications